Sale of 13,000 shares at $46.6707 per share.
Reporting Person Garland J. Scott · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001533228-26-000009 · filed 2026-10-05 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Enliven Therapeutics, Inc. (ELVN)." Disclosed 2026-10-05. https://desqlong.com/cards/0001533228-26-000009-2 (retrieved 2026-10-06).